Loading organizations...
§ Private Profile · 205 West 28th Street, NY, USA
Layer-1 blockchain for finance, enabling decentralized finance applications for institutions and users, focused on high-speed trading
Injective has raised $63.0M across 4 funding rounds.
Key people at Injective.
Injective was founded in 2018 by Albert Chon (Co-Founder and CTO).
Injective has raised $63.0M in total across 4 funding rounds.
Injective is a layer-1 blockchain specifically engineered for finance, enabling fast, permissionless, and censorship-resistant decentralized exchanges and financial applications. The network has demonstrated significant scale, processing over $50 billion in trading volume and more than 2 billion on-chain transactions, serving an ecosystem of over 1.5 million wallets. The organization has raised $56 million in funding from investors, contributing to its $1.34 billion valuation. Prominent investors include Binance, Pantera, Jump Crypto, BitGo, and Mark Cuban, reflecting broad industry backing. Injective provides infrastructure for developers and institutions to build transparent global markets, aiming to reinvent traditional finance. It was founded in 2018 by Eric Chen and Albert Chon. Its business model centers on raises funding from investors to develop and scale its blockchain infrastructure, generated through network activity including trading volume and transactions on its decentralized finance ecosystem.
Injective has raised $63.0M across 4 funding rounds. Most recently, it raised $40.0M Other Equity in August 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jul 9, 2024 | Build on Bitcoin | $1.6M Other Equity | Marguerite DE Tavernost | Aave Foundation, Babylon, BlackRock, Centrifuge, Curve, Magic Eden, Mechanism, Ordinals, Rarible, MacLane Wilkison, Vessel Capital |
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 10, 2022 | $40M Venture Round | Kanav Kariya | Brevan Howard Digital | Announced |
| Apr 20, 2021 | $10M Venture Round | — | Mark Cuban, BlockTower Capital, Cadenza Ventures, CMS, Hashed, Pantera Capital, QCP Capital | Announced |
| Apr 1, 2021 | $10M Series U | — | Grasshopper Capital, Pantera Capital, BlockTower Capital, Cadenza Ventures, CMS, Hashed, Mark Cuban, QCP Capital | Announced |
| Jul 1, 2020 | $3M Seed | Pantera Capital | Grasshopper Capital, Symbolic Capital, Axia8 Ventures, Bitlink Capital, Bitscale Capital, BoxOne Ventures, Cabin VC, Innovating Capital, K42, Krypital Group, QCP Soteria | Announced |
Injective was founded in 2018 by Albert Chon (Co-Founder and CTO).
Injective has raised $63.0M in total across 4 funding rounds.
Injective's investors include Kanav Kariya, Brevan Howard Digital, Mark Cuban, BlockTower Capital, Cadenza Ventures, CMS, Hashed, Pantera Capital, QCP Capital, Grasshopper Capital, Symbolic Capital, Axia8 Ventures.
Injective is a Layer 1 blockchain optimized for Web3 finance, providing developers with an open, interoperable network for decentralized finance (DeFi) applications, including secure transactions, near-instant finality, zero gas fees, and high throughput up to 25,000 transactions per second (TPS).[1][3][4][5] It serves DeFi developers, institutions, and users building financial apps like orderbook exchanges, real-world asset (RWA) tokenization, NFTs, and cross-chain solutions, solving key blockchain limitations such as high fees, slow speeds, and poor interoperability with chains like Ethereum and Solana.[1][3][4] Growth momentum includes a $150 million ecosystem fund launched in 2023, over $500 million in iAssets trading volume with 60% weekly market share in on-chain equities, and evolution from a Layer 2 to a full Layer 1 with CosmWasm upgrades.[2][4]
Injective was founded in 2018 by Eric Chen and Albert Chon through Binance Labs' first incubation program, initially launching as a Layer 2 solution for DeFi trading on Ethereum.[1][2][4] Chen and Chon, with backgrounds in blockchain and finance, identified gaps in existing DeFi platforms—rudimentary tools, high costs, and security issues—leading to Injective Labs' creation of a high-performance network.[2][4] Early traction came with a testnet DeFi platform in December 2020, a $10 million funding round in April 2021 backed by Mark Cuban, and a CosmWasm mainnet upgrade in July 2021 for scalable smart contracts, followed by the $150 million ecosystem fund in January 2023 to boost DeFi and infrastructure adoption.[2]
Injective rides the DeFi and Web3 finance wave, capitalizing on surging demand for tokenized RWAs, institutional-grade on-chain trading, and interoperable blockchains amid maturing crypto markets.[3][4] Its timing aligns with Cosmos ecosystem expansion and Ethereum's scaling challenges, offering faster, cheaper alternatives that draw liquidity from fragmented chains.[3] Market forces like regulatory clarity for RWAs and rising institutional adoption favor Injective's high TPS and CLOB, positioning it as infrastructure for global finance while influencing the ecosystem through its $150M fund and 60% on-chain equities dominance.[2][4]
Injective is poised to expand as a DeFi powerhouse, with iAssets and cross-chain bridges driving RWA tokenization growth amid trends like AI-integrated finance and multi-chain liquidity.[3][4] Upcoming developments may include enhanced MultiVM capabilities and deeper institutional integrations, amplifying its role in a $trillion+ tokenized asset market.[4][5] As blockchain finance matures, Injective's speed and zero-fee model will likely solidify its edge, evolving from DeFi innovator to foundational Web3 financial layer—echoing its origins as a Binance-incubated disruptor now scaling global apps.[2][4]
Key people at Injective.
